• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

原发性人类黑色素瘤中的Ki-67抗原——其与有丝分裂率、肿瘤厚度的关系及其稳定性。

The Ki-67 antigen in primary human melanomas--its relationship to mitotic rate and tumor thickness and its stability.

作者信息

Ostmeier H, Suter L

机构信息

Fachklinik Hornheide, Münster, Federal Republic of Germany.

出版信息

Arch Dermatol Res. 1989;281(3):173-7. doi: 10.1007/BF00456388.

DOI:10.1007/BF00456388
PMID:2774644
Abstract

We investigated whether two parameters of proliferative activity - mitotic rate and Ki-67 positive cells - are interchangeable. The mitotic rate was assessed on paraffin-embedded sections, Ki-67 positive cells were immunohistologically determined in frozen tissue. A poor correlation (correlation coefficient r = 0.57) was found between both parameters. The proliferative activity was often not homogeneously distributed in the tested tumors. However, this is a major reason for the observed difference only in thin melanomas (less than 1.5 mm) as seen by comparison of tumors with homogeneous and inhomogeneous proliferative activity. We assume that arrest of cells in different stages of the cell cycle - variable from melanoma to melanoma - is the major reason for the observed discrepancy between mitotic rate and Ki-67 positive cells in tumors of 1.5 mm and thicker. The mean number of Ki-67 positive cells increased with tumor thickness. The stability of the Ki-67 antigen towards freezing, thawing, and formalin was studied.

摘要

我们研究了增殖活性的两个参数——有丝分裂率和Ki-67阳性细胞——是否可相互替代。有丝分裂率在石蜡包埋切片上评估,Ki-67阳性细胞在冰冻组织中通过免疫组织化学方法测定。发现这两个参数之间相关性较差(相关系数r = 0.57)。在受试肿瘤中,增殖活性通常分布不均一。然而,这仅是在薄黑色素瘤(小于1.5毫米)中观察到差异的主要原因,通过比较增殖活性均一和不均一的肿瘤可见。我们推测,细胞在细胞周期不同阶段的停滞——因黑色素瘤而异——是在1.5毫米及更厚的肿瘤中观察到的有丝分裂率与Ki-67阳性细胞之间差异的主要原因。Ki-67阳性细胞的平均数量随肿瘤厚度增加。研究了Ki-67抗原对冷冻、解冻和福尔马林的稳定性。

相似文献

1
The Ki-67 antigen in primary human melanomas--its relationship to mitotic rate and tumor thickness and its stability.原发性人类黑色素瘤中的Ki-67抗原——其与有丝分裂率、肿瘤厚度的关系及其稳定性。
Arch Dermatol Res. 1989;281(3):173-7. doi: 10.1007/BF00456388.
2
Nuclear morphometry, immunohistochemical staining with Ki-67 antibody and mitotic index in the assessment of proliferative activity and prognosis of primary malignant melanomas of the skin.细胞核形态测量、Ki-67抗体免疫组化染色及有丝分裂指数在皮肤原发性恶性黑色素瘤增殖活性及预后评估中的应用
J Cutan Pathol. 1996 Aug;23(4):335-43. doi: 10.1111/j.1600-0560.1996.tb01307.x.
3
Comparison of proliferative activity as assessed by proliferating cell nuclear antigen (PCNA) and Ki-67 monoclonal antibodies in melanocytic skin lesions. A quantitative immunohistochemical study.
J Cutan Pathol. 1993 Jun;20(3):229-36. doi: 10.1111/j.1600-0560.1993.tb00648.x.
4
Correlation of Ki-67 expression in cutaneous primary melanoma with prognosis in a prospective study: different correlation according to thickness.
J Am Acad Dermatol. 2001 Feb;44(2):188-92. doi: 10.1067/mjd.2001.110067.
5
Ki 67 immunostaining in melanocytic skin tumors. Correlation with histologic parameters.黑素细胞性皮肤肿瘤中的Ki 67免疫染色。与组织学参数的相关性。
J Cutan Pathol. 1991 Aug;18(4):264-72. doi: 10.1111/j.1600-0560.1991.tb01234.x.
6
Prognostic value of Ki-67 expression in localized cutaneous malignant melanoma.Ki-67表达在局限性皮肤恶性黑色素瘤中的预后价值
J Am Acad Dermatol. 2000 Dec;43(6):991-1000. doi: 10.1067/mjd.2000.109282.
7
[Correlation between tumor cell proliferation and prognosis of primary cutaneous malignant melanoma in 127 patients].127例原发性皮肤恶性黑色素瘤患者肿瘤细胞增殖与预后的相关性
Zhonghua Bing Li Xue Za Zhi. 2013 Mar;42(3):178-81. doi: 10.3760/cma.j.issn.0529-5807.2013.03.008.
8
Tumor cell growth fractions in human malignant melanomas and the correlation to histopathologic tumor grading.人类恶性黑色素瘤中的肿瘤细胞生长分数及其与组织病理学肿瘤分级的相关性。
Am J Pathol. 1989 May;134(5):1063-8.
9
Prognostic significance of MIB-1 proliferative activity in thin melanomas and immunohistochemical analysis of MIB-1 proliferative activity in melanocytic tumors.MIB-1增殖活性在薄型黑色素瘤中的预后意义及黑色素细胞肿瘤中MIB-1增殖活性的免疫组化分析
Am J Dermatopathol. 1998 Feb;20(1):12-6. doi: 10.1097/00000372-199802000-00003.
10
Mitotic cyclins and cyclin-dependent kinases in melanocytic lesions.
Hum Pathol. 1998 Oct;29(10):1085-90. doi: 10.1016/s0046-8177(98)90418-x.

引用本文的文献

1
The proliferative activity levels of each immune cell population evaluated by mass cytometry are linked to the clinical phenotypes of systemic lupus erythematosus.通过液质联用技术评估的每种免疫细胞群体的增殖活性水平与系统性红斑狼疮的临床表型相关。
Int Immunol. 2023 Jan 21;35(1):27-41. doi: 10.1093/intimm/dxac042.
2
The relationship between characteristics of the tumor cells and sex of the patients in primary malignant melanomas.原发性恶性黑色素瘤中肿瘤细胞特征与患者性别的关系。
J Cancer Res Clin Oncol. 1991;117(4):364-6. doi: 10.1007/BF01630721.
3
The relationship between Ki-67 labeling and mitotic index in gliomas and meningiomas: demonstration of the variability of the intermitotic cycle time.

本文引用的文献

1
Kinetic heterogeneity in density-separated murine fibrosarcoma subpopulations.密度分离的小鼠纤维肉瘤亚群中的动力学异质性。
Cancer Res. 1982 Dec;42(12):4999-5003.
2
Prognostic factors for patients with clinical stage I melanoma of intermediate thickness (1.51 - 3.39 mm). A conceptual model for tumor growth and metastasis.临床分期为Ⅰ期的中等厚度(1.51 - 3.39毫米)黑色素瘤患者的预后因素。肿瘤生长和转移的概念模型。
Ann Surg. 1982 Jan;195(1):35-43. doi: 10.1097/00000658-198201001-00006.
3
Characterization of hematologic malignancies by flow cytometry.
胶质瘤和脑膜瘤中Ki-67标记与有丝分裂指数之间的关系:有丝分裂间期时间变异性的证明
Acta Neuropathol. 1991;82(5):389-94. doi: 10.1007/BF00296550.
4
p-glycoprotein expression in malignant melanoma.恶性黑色素瘤中P-糖蛋白的表达
J Cancer Res Clin Oncol. 1991;117(2):168-71. doi: 10.1007/BF01613142.
5
Comparison of proliferation rates assessed using "multiblock" and conventional tissue blocks of lung carcinoma.使用“多块”肺癌组织块与传统组织块评估增殖率的比较。
J Clin Pathol. 1992 Jul;45(7):579-82. doi: 10.1136/jcp.45.7.579.
通过流式细胞术对血液系统恶性肿瘤进行特征分析。
Blood Cells. 1980;6(4):719-44.
4
Factors associated with death from melanoma from 2 to 5 years following diagnosis in clinical stage I patients.临床I期患者诊断后2至5年与黑色素瘤死亡相关的因素。
J Invest Dermatol. 1983 Jun;80 Suppl:53s-55s.
5
The proliferative activity of cells of malignant melanomas.恶性黑色素瘤细胞的增殖活性。
Am J Dermatopathol. 1984 Summer;6 Suppl:317-23.
6
Prognostic significance of the patient's sex, tumor site, and mitotic rate in thin (less than or equal to 1.5 mm) melanoma.患者性别、肿瘤部位及有丝分裂率在薄型(小于或等于1.5毫米)黑色素瘤中的预后意义。
Arch Dermatol Res. 1984;276(3):151-5. doi: 10.1007/BF00414011.
7
Cultured human tumour cells may be arrested in all stages of the cycle during stationary phase: demonstration of quiescent cells in G1, S and G2 phase.
Cell Tissue Kinet. 1984 Sep;17(5):453-63. doi: 10.1111/j.1365-2184.1984.tb00604.x.
8
Growth fractions in malignant non-Hodgkin's lymphomas (NHL) as determined in situ with the monoclonal antibody Ki-67.采用单克隆抗体Ki-67原位测定恶性非霍奇金淋巴瘤(NHL)的生长分数。
Hematol Oncol. 1984 Oct-Dec;2(4):365-71. doi: 10.1002/hon.2900020406.
9
Production of a mouse monoclonal antibody reactive with a human nuclear antigen associated with cell proliferation.产生一种与细胞增殖相关的人类核抗原有反应性的小鼠单克隆抗体。
Int J Cancer. 1983 Jan 15;31(1):13-20. doi: 10.1002/ijc.2910310104.
10
Cell cycle analysis of a cell proliferation-associated human nuclear antigen defined by the monoclonal antibody Ki-67.用单克隆抗体Ki-67对一种与细胞增殖相关的人类核抗原进行细胞周期分析。
J Immunol. 1984 Oct;133(4):1710-5.